Literature DB >> 25298851

Endovascular treatment in acute ischemic stroke patient on factor Xa inhibitor.

Siddhart Mehta1, Haitham Dababneh1, Mohammed Hussain2, Mohammad Moussavi2, Jawad F Kirmani2.   

Abstract

Entities:  

Keywords:  factor Xa inhibitor; intra-arterial tPA(IA tPA); rivaroxaban; stroke

Year:  2014        PMID： 25298851      PMCID： PMC4188251     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN： 1941-5893


× No keyword cloud information.
  14 in total

1.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Intra-arterial thrombolysis in patients treated with warfarin.

Authors:  Italo Linfante; Arra S Reddy; Vincenzo Andreone; Louis R Caplan; Magdy Selim; Joshua A Hirsch
Journal:  Cerebrovasc Dis       Date:  2005-01-05       Impact factor: 2.762

3.  Periprocedural management of patients on dabigatran etexilate treatment.

Authors:  M Watanabe; A I Qureshi; F M Siddiqui
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

4.  Intravenous thrombolysis in a stroke patient taking dabigatran.

Authors:  Vivien H Lee; James J Conners; Shyam Prabhakaran
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-05-16       Impact factor: 2.136

Review 5.  Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment.

Authors:  Masaki Watanabe; Fazeel M Siddiqui; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

6.  Safety of intra-arterial thrombolysis in the postoperative period.

Authors:  J A Chalela; I Katzan; D S Liebeskind; P Rasmussen; O Zaidat; J I Suarez; D Chiu; R P Klucznick; E Jauch; B L Cucchiara; J Saver; S E Kasner
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

7.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

8.  Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association.

Authors:  H P Adams; T G Brott; A J Furlan; C R Gomez; J Grotta; C M Helgason; T Kwiatkowski; P D Lyden; J R Marler; J Torner; W Feinberg; M Mayberg; W Thies
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

9.  Feasibility of IA thrombolysis for acute ischemic stroke among anticoagulated patients.

Authors:  Nazli Janjua; Ammar Alkawi; Alexandros Georgiadis; M Fareed K Suri; M Salim Ibrahim; Jawad F Kirmani; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

10.  Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.

Authors:  Harold P Adams; Gregory del Zoppo; Mark J Alberts; Deepak L Bhatt; Lawrence Brass; Anthony Furlan; Robert L Grubb; Randall T Higashida; Edward C Jauch; Chelsea Kidwell; Patrick D Lyden; Lewis B Morgenstern; Adnan I Qureshi; Robert H Rosenwasser; Phillip A Scott; Eelco F M Wijdicks
Journal:  Circulation       Date:  2007-05-22       Impact factor: 29.690
View more
  2 in total

Review 1.  Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.

Authors:  Amish N Raval; Joaquin E Cigarroa; Mina K Chung; Larry J Diaz-Sandoval; Deborah Diercks; Jonathan P Piccini; Hee Soo Jung; Jeffrey B Washam; Babu G Welch; Allyson R Zazulia; Sean P Collins
Journal:  Circulation       Date:  2017-02-06       Impact factor: 29.690

Review 2.  Use of rivaroxaban in patients with stroke.

Authors:  Danilo Toni; Antonio Carolei; Valeria Caso; Domenico Consoli; Massimo Del Sette; Domenico Inzitari; Maurizio Melis; Giuseppe Micieli; Leandro Provinciali; Stefano Ricci; Paola Santalucia; Vito Toso
Journal:  Neurol Sci       Date:  2017-02-25       Impact factor: 3.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.